Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)
The purpose of this study is to determine duration before progression of first-line treatment chemotherapy following erlotinib in second-line comparing erlotinib in first-line following chemotherapy in second-line in old patients with none small cell lung cancer.
Non Small Cell Lung Cancer
DRUG: Erlotinib|DRUG: taxotere
A multicenter phase II trial , prospective, randomized, open, non comparative